Associated Papers
Risks and Implications of Multiple Actionable Pathogenic Germline Variants Discovered by Panel-Based Cancer Predisposition Testing.
Neumann C et al.
Jco Precision Oncology, 2025
41100774 (PubMed )
Supplement: po-9-e2400951-s001.pdf
Select a paper to view details